News
The new nasal vaccine only needs one dose and produces reliable immunity right at the site where the virus enters the body.
Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...
Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...
The scientists significantly reduced nasal inflammation and improved the sense of smell in mice by using a vitamin D nasal spray, according to a study published in the journal International Forum of ...
I was yesterday years old when I learned there was a wrong way to use [nasal spray] Flonase,” content creator Amber Guttilla said in a viral TikTok.
Milestone Pharmaceuticals faces an FDA setback for its PSVT nasal spray. The company coordinates with regulatory authorities to resolve CRL issues.
after the company announced receipt of a complete response letter from the FDA regarding its new drug application for its etripamil nasal spray for the treatment of paroxysmal supraventricular ...
(NASDAQ:MIST) shares plummeted 60% following a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) concerning its New Drug Application (NDA) for CARDAMYST™ (etripamil) ...
Etripamil, Milestone’s lead investigational product, is a calcium channel blocker nasal spray designed for self-administration by patients to convert acute episodes of PSVT to sinus rhythm, ...
Etripamil is Milestone's lead investigational product. It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results